The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy


Resorlu B., Beduk Y., BALTACI S., Ergun G., Talas H.

BJU International, vol.103, no.4, pp.480-483, 2009 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 103 Issue: 4
  • Publication Date: 2009
  • Doi Number: 10.1111/j.1464-410x.2008.08033.x
  • Journal Name: BJU International
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.480-483
  • Keywords: Age, Bladder cancer, Cystectomy, Elderly patients, Prognosis, Survival
  • Ankara University Affiliated: Yes

Abstract

OBJECTIVE: To evaluate the association of patient age with pathological and long-term oncological outcomes after radical cystectomy (RC) for bladder carcinoma, as this disease, like many others, increases in incidence with age. PATIENTS AND METHODS: We retrospectively reviewed 241 consecutive patients with invasive bladder cancer who had RC between 1990 and 2007. The age at RC was analysed both as a continuous and categorical (≤50 years, 38 patients; 51-69, 172; or ≥70, 31) variable. Survival was also analysed. RESULTS: Increasing age, analysed as a continuous and categorical variable, was associated with advanced pathological stage (P = 0.009 and 0.006, respectively). The 5-year cancer-specific survival rates for patients according to the age groups were 78.5%, 44.9% and 28.1%, respectively, and Kaplan-Meier analysis showed an increased risk of bladder cancer-specific death with advancing age (P < 0.001). Being older at RC was an important prognostic factor for disease-specific survival in a multivariate Cox regression model. Patients aged ≥70 years had a significantly higher risk of disease than patients aged ≤50 years (P = 0.002). CONCLUSIONS: Higher age at RC is significantly associated with the risk of pathologically advanced disease and poorer cancer-specific survival. More prospective work is needed to examine the impact of age on tumour biology and cancer-specific survival. © 2008 The Authors.